| Added by | standudu |
|---|---|
| Group name | EquipeCTCS |
| Item Type | Journal Article |
| Title | Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database |
| Creator | Goulabchand et al. |
| Author | Radjiv Goulabchand |
| Author | Nicolas Malafaye |
| Author | William Jacot |
| Author | Philine Witkowski Durand Viel |
| Author | Jacques Morel |
| Author | Cédric Lukas |
| Author | Pauline Rozier |
| Author | Sylvain Lamure |
| Author | Nicolas Molinari |
| Author | Thibault Mura |
| Author | Philippe Guilpain |
| Abstract | The relationship between cancer and primary Sjögren's syndrome (pSS) is uncertain. While the increased risk of hematological malignancies is well-known, data on the comparative incidence of solid neoplasms is conflicting. This study aimed to explore the associations between cancer and pSS. This nationwide population-based retrospective study from the French health insurance database (PMSI) evaluated patients hospitalized with new-onset pSS from 2011 to 2018 against age- and sex-matched hospitalized controls (1:10). The incidence of hematological malignancies and solid neoplasms was compared between the two groups. Mortality and multiple cancer incidence were also evaluated. Adjusted Hazard Ratios (aHR) calculations included confounding factors, such as low socioeconomic status. Among 25,661 hospitalized patients with pSS versus 252,543 matched patients (median follow-up of 3.96 years), we observed a higher incidence rate of lymphomas (aHR, 1.97 [95% CI, 1.59-2.43]), Waldenström macroglobulinemia (aHR, 10.8 [6.5-18.0]), and leukemia (aHR, 1.61 [1.1-2.4]). Thyroid cancer incidence was higher (aHR, 1.7 [1.1-2.8]), whereas bladder and breast cancer incidences were lower (aHR, 0.58 [0.37-0.89] and 0.60 [0.49-0.74], respectively). pSS patients with breast cancer exhibited a lower mortality rate. A limitation was that the database only encompasses hospitalized patients, and immunological and histological details are not listed. We confirmed the increased risk of hematological malignancies and thyroid cancers among patients with pSS. The lower risk of breast cancer suggests a role of hormonal factors and raises questions of the concept of immune surveillance within breast tissue. Epidemiological and translational studies are required to elucidate the relationships between pSS and cancer. |
| Publication | Autoimmunity Reviews |
| Volume | 20 |
| Issue | 12 |
| Pages | 102987 |
| Date | 2021-12 |
| Journal Abbr | Autoimmun Rev |
| Language | eng |
| DOI | 10.1016/j.autrev.2021.102987 |
| ISSN | 1873-0183 |
| Short Title | Cancer incidence in primary Sjögren's syndrome |
| Library Catalog | PubMed |
| Extra | PMID: 34718160 |
| Tags | Cancer incidence, Epidemiology, Hematological malignancies, Hospitalization, Humans, Incidence, marque, Neoplasms, Primary Sjögren's syndrome, Retrospective Studies, review, Risk Factors, Sjogren's Syndrome, Solid neoplasms |
| Date Added | 2022/07/29 - 12:00:27 |
| Date Modified | 2022/08/01 - 12:25:49 |
| Notes and Attachments | PubMed entry (Attachment) |
Institut de Recherche en Cancérologie de
